Etteplan Oyj (ETTE)
Nasdaq Helsinki · Finland · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 7.640 |
|---|---|
| 52-week range | 7.020 – 10.000 |
| Return, 1 month / 3 months | −4.5% / −0.8% |
| Return, 1 year / 3 years | −20.6% / −39.5% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -26.3% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Etteplan Oyj is a technology consultancy based in Finland that helps industrial companies with engineering design, embedded systems and software, and technical documentation. Its engineers work on product development and production solutions for manufacturers of machinery, equipment and other industrial goods, and the firm also offers services around maintenance and digital operations. Customers are mainly businesses in the manufacturing and process industries, served from offices in Finland and other European countries as well as in Asia.
The shares are listed on the Nasdaq Helsinki in Finland under the code ETTE, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Etteplan Oyj (ETTE) trades on the Nasdaq Helsinki in Finland. It last closed at EUR 7.640 on 27 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 101 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.6% and over the last three months it fell 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Helsinki
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.2% | ||
| From 52-week high | -22.8% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.8% | ||
| 6-month return | 3.2% | ||
| 12-month return, skipping the last month | -16.9% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.3% | ||
| Liquidity | 17 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | −4.5% |
| 3 months | −0.8% |
| 6 months | +3.2% |
| 1 year | −20.6% |
| 3 years | −39.5% |
| 5 years | −52.8% |
Signals
| 50-day / 200-day average | 8.090 / 7.975 |
|---|---|
| Golden / death cross (60 days) | Golden, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.140 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Apr 2026 | EUR 0.2200 |
| 9 Apr 2025 | EUR 0.2200 |
| 10 Apr 2024 | EUR 0.3000 |
| 6 Apr 2023 | EUR 0.3600 |
| 7 Apr 2022 | EUR 0.4000 |
| 9 Apr 2021 | EUR 0.3400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Helsinki; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.